A new study shows that tumors with mutations in genes leading to over-activation of the NF-kB signaling pathway were more than three times as likely to respond to anti-PD1 immunotherapy compared with tumors in which these changes were absent.
from Latest Science News -- ScienceDaily https://ift.tt/2UqpAlX
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment